Can a denser dose of rituximab stop ITP relapses in kids?
NCT ID NCT04323748
First seen Apr 25, 2026 · Last updated May 22, 2026 · Updated 7 times
Summary
This study tests whether giving rituximab more frequently (dose dense) can improve remission and reduce relapse in children and teens aged 1 to 21 with newly diagnosed, high-risk immune thrombocytopenic purpura (ITP). Participants must have a very low platelet count and at least one high-risk feature like age 10 or older, significant bleeding, or a positive ANA test. The study will monitor safety and how many patients achieve a stable platelet count without needing long-term medication.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNE THROMBOCYTOPENIC PURPURA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
New York Medical College
RECRUITINGVahalla, New York, 10595, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.